AGENDA – February 19 – 20, 2021

Robot-Assisted Radical Prostatectomy
8:10–10:20 am
Prostate Session I – Hood Technique
Robotic-assisted radical prostatectomy (RARP), the frontline approach for prostate cancer presents challenges to recovery. However, the RARP “hood technique” may address the competing goals of cancer control, maintenance of urinary continence, and recovery of sexual function. Early return of continence after surgery, without compromising positive surgical margin rates is observed with the hood technique. This technique spares musculofascial structures anterior to the urethral sphincter complex.
10:30-11:40 am
Kidney Session I – Complex Partial
Minimally invasive nephron sparing surgery has become increasingly popular as expertise in laparoscopy has increased and has demonstrated excellent long-term renal functional and oncological outcome, The da Vinci® surgical system may facilitate performing these complex renal tumors using the minimally invasive surgical approach. we will explain State of the art technique of robotic partial nephrectomy in the setting of complex renal tumors, including hilar, endophytic, and multiple tumors
Several techniques have been described to improve outcomes after RPN. the literature shows that RPN is as good if not better than both LPN and OPN and has become the preferred surgical approach.

Moderators:

Comments:

11:50–1:00 pm
Bladder Session I – Single Port Female Cystectomy
Cystectomy is the standard treatment for bladder recurrent, high‐risk non‐muscle‐invasive and localized muscle‐invasive urothelial carcinoma of the bladder. The da Vinci single-port instrument configuration allows the surgeon to work in narrow spaces. The instruments also have an extra joint providing an ‘elbow’, enhancing the triangulation experience around the target anatomy. The system features: a high‐definition three‐dimensional camera, an instrument guidance system, and enhanced instrument arm control.

Moderators:

1:00–1:40 pm
SPONSORED LUNCH SEMINAR
1:40–2:50 pm
Prostate Session II – Retzius Sparing
Avoiding the Retzius structures involved in continence and potency preservation and passing through the pouch of Douglas can be oncologically safe and can result in high early continence and potency rates.
3:00–4:10 pm
Kidney Session II – Retroperitoneal – Single Port
The retroperitoneal approach is technically feasible and safe for treatment of various urologic diseases, resulting in better cosmetic outcomes, lower postoperative analgesic requirements, and faster convalescence than is available with conventional laparoscopy, we will discuss the advantage and disadvantage of retroperitoneal single-site robot-assisted partial nephrectomy (R-SSRPN) using the da Vinci Xi surgical system.

Moderators:

4:20–5:30 pm
Bladder Session II – Male Nerve Sparing Cystectomy with NeoBladder
Male Nerve Sparing Cystectomy with NeoBladder can improve early to urinary continence and erectile function.

Surgeon:

Moderators:

8:10–10:20 am
Prostate Session III – Single Port
Surgical treatment for prostate cancer is transforming. The novel da Vinci Surgical System for single port system is safe and feasible. The approach presents satisfactory outcomes for: operative time, hospital stay, pain requirements, catheterisation time, and complications. Patients have reported favourable ratings for scar cosmesis as compared to conventional laparoscopic or open approaches after kidney surgery.
10:30–11:40 am
Kidney Session III – Radical Nephrectomy
In select cases and experienced hands, robotic approach offers a reasonable alternative to open surgery without an increased complication rate.

Moderators:

Comments:

11:50 am–1:00 pm
Bladder Session III – Male Cystectomy: Ileal Conduit
Robot-assisted radical cystectomy (RARC) is an increasingly common treatment approach for bladder cancer. RARC replicates the oncologic outcomes of open surgery while providing benefits of a minimally invasive approach. Additionally, an ileal conduit is feasible and can shorten operative time as compared to neobladder methods.

Moderators:

1:00–1:40 pm
SPONSORED LUNCH SEMINAR
1:40–2:50 pm
Prostate Session IV – Foundations and Outcomes
Radical prostatectomy (RP) is the most frequent treatment for prostate cancer. The main objective of RP is oncological control. Additionally, it is ideal for RP to manage negative biochemical recurrence, negative surgical margins, total continence, adequate erectile function, and absence of perioperative complications.

Moderators:

3:00–4:10 pm
Kidney Session IV – RPLND
RPLND can affect oncologic outcomes. It is possible that robotic approaches make these steps of the procedure technically easier and better patient experience.